Reason: Subpotent Drug: low Anti-Factor IIa potency.
Distributed: Nationwide in the USAReason: Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.
Distributed: Nationwide in the USAReason: Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Distributed: Nationwide in the USAReason: Packaging defect: observed packaging defect, blister packaging inadequately sealed.
Distributed: Distributed Nationwide in the USAReason: CGMP Deviations: recalling drug products following an FDA inspection.
Distributed: United States including Puerto Rico and CanadaReason: CGMP Deviations: recalling drug products following an FDA inspection.
Distributed: United States including Puerto Rico and CanadaReason: CGMP Deviations: recalling drug products following an FDA inspection.
Distributed: United States including Puerto Rico and CanadaReason: CGMP Deviations: recalling drug products following an FDA inspection.
Distributed: United States including Puerto Rico and CanadaReason: CGMP Deviations: recalling drug products following an FDA inspection.
Distributed: United States including Puerto Rico and CanadaReason: CGMP Deviations: recalling drug products following an FDA inspection.
Distributed: United States including Puerto Rico and Canada